Re: Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
26 July 2010 | pages 311 - 312
archive
Jump to
European Urology
Volume 58, issue 2, pages e19-e28, August 2010Viewing articles 31-40 of 46
topWords of Wisdom
Re: Effect of Dutasteride on the Risk of Prostate Cancer
26 July 2010 | page 312
Re: Effect of Dutasteride on the Risk of Prostate Cancer
26 July 2010 | page 313
Re: Does Oral Antiandrogen Use Before Leuteinizing Hormone-Releasing Therapy in Patients with Metastatic Prostate Cancer Prevent Clinical Consequences of a Testosterone Flare?
26 July 2010 | pages 314 - 315
Re: Retrospective Analysis of Prostate Cancer Recurrence Potential with Tissue Metabolomic Profiles
26 July 2010 | page 315
Re: Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
26 July 2010 | page 316
topLetters to the Editor published online
Re: Noel W. Clarke, Michael Marberger. The Motion: GnRH Antagonists are the New Way Forward in Hormonal Therapy. Eur Urol 2010;57:534–7
21 April 2010 | page e20
Re: Derya Tilki, Oliver Reich, Pierre I. Karakiewicz, et al. Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome. Eur Urol 2010;58:112–7
23 April 2010 | pages e21 - e22
Viewing articles 31-40 of 46
Copyright © 